22nd Century Group Reports Preliminary FY25 Results; Shareholders Approve Reverse Split & Future Dilution

check_boxKey Events

• Preliminary Q4 & FY 2025 Financial Results Released

  The company reported preliminary Q4 2025 net revenues of $3.6 million and full-year 2025 net revenues of $17.6 million. Operating loss improved to $2.8 million in Q4 and $11.6 million for the full year. Crucially, the company ended 2025 with $7.1 million in cash and zero long-term debt, significantly strengthening its balance sheet.

• Shareholders Approve Reverse Stock Split

  Shareholders approved an amendment to effect a reverse stock split at a ratio between 1-for-2 and 1-for-200, at the Board's discretion, to comply with Nasdaq Listing Rules. This follows the company's announcement on January 22, 2026, of its intent to implement a reverse split.

• Authorizations for Future Dilution Approved

  Shareholders approved proposals allowing the issuance of Series A Convertible Preferred Stock below the Nasdaq Minimum Price and authorizing a potential future offering. These approvals provide the company with mechanisms for future capital raises, which could lead to significant dilution for existing shareholders.

auto_awesomeAnalysis

This filing presents a mixed but highly significant picture for 22nd Century Group. On one hand, the company has substantially improved its financial footing, ending 2025 with $7.1 million in cash and, critically, zero long-term debt. This provides a vital lifeline and runway for a micro-cap company, especially following a strategic shift to exit unprofitable revenue streams, which is reflected in improved operating and net losses despite a revenue decline. This financial stability is a strong positive signal for near-term survival.

However, shareholders also approved several measures that signal significant potential future dilution. The approval of a reverse stock split (between 1-for-2 and 1-for-200) is a necessary step to maintain NASDAQ listing but generally reflects a struggling stock price. More concerning are the approvals to issue Series A Convertible Preferred Stock below the Nasdaq Minimum Price and for a potential future offering. These authorizations grant the company flexibility to raise capital, but at the risk of substantial dilution to existing shareholders. Investors should weigh the improved balance sheet and liquidity against the clear path for future dilutive capital raises.